Tumor microenvironment in primary central nervous system lymphoma (PCNSL)

Area of Science:

• Neuro-oncology
• Immunology
• Hematology

Background:

• Primary central nervous system lymphoma (PCNSL) is a rare malignancy confined to the CNS.
• The tumor microenvironment (TME) is crucial for cancer progression and immunotherapy response.
• Systematic characterization of the PCNSL TME is lacking.

Purpose of the Study:

• To systematically review and characterize the TME of PCNSL.
• To compare the PCNSL TME with that of systemic diffuse large B-cell lymphoma (DLBCL).
• To understand the implications of TME characteristics for PCNSL immunosuppression.

Main Methods:

• Literature review of existing research on PCNSL and its TME.
• Analysis of immune cell infiltration patterns (TAMs, TILs, CTLs, M2 macrophages).
• Evaluation of immune evasion mechanisms including checkpoint expression and cytokine release.

Main Results:

• PCNSL TME is infiltrated by tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs), notably cytotoxic T cells (CTLs) and M2 macrophages.
• Immune cell infiltration in PCNSL is lower compared to systemic DLBCL.
• PCNSL TME exhibits significant immunosuppression via immunosuppressive cells, reduced HLA I/II expression, checkpoint overexpression, and immunosuppressive cytokines.

Conclusions:

• The PCNSL TME is characterized by a prominent immunosuppressive milieu.
• PCNSL demonstrates stronger immunosuppressive properties than systemic DLBCL.
• Understanding PCNSL TME is critical for developing effective immunotherapies.